FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Karen Douville

Research Profile

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Anatomy

COS Cells

Living Beings

Cercopithecus aethiops

Co-author Network

Publications

TOP 3
Zsolt Kasza; Kristina M Fetalvero; Min Ding; Robert J Wagner; Klara Acs; Anthony K Guzman; Karen Douville; Richard J Powell; John Hwa; Kathleen A Martin
Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation.
Eric J Arehart; Jeremiah Stitham; Folkert Asselbergs; Karen Douville; Todd MacKenzie; Kristina M Fetalvero; Scott R Gleim; Zsolt Kasza; Yamini Rao; Laurie Martel; Sharon Segel; John Robb; Aaron Kaplan; Michael Simons; Richard J Powell; Jason Moore; Eric B Rimm; Kathleen A Martin; John Hwa
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.
Jeremiah Stitham; Eric J Arehart; Scott R Gleim; N Li; Karen Douville; John Hwa
New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Karen Douville (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Zsolt Kasza; Kristina M Fetalvero; Min Ding; Robert J Wagner; Klara Acs; Anthony K Guzman; Karen Douville; Richard J Powell; John Hwa; Kathleen A Martin
Novel signaling pathways promote a paracrine wave of prostacyclin-induced vascular smooth muscle differentiation.
Journal of molecular and cellular cardiology 2009;46(5):682-94.
2008: Eric J Arehart; Jeremiah Stitham; Folkert Asselbergs; Karen Douville; Todd MacKenzie; Kristina M Fetalvero; Scott R Gleim; Zsolt Kasza; Yamini Rao; Laurie Martel; Sharon Segel; John Robb; Aaron Kaplan; Michael Simons; Richard J Powell; Jason Moore; Eric B Rimm; Kathleen A Martin; John Hwa
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition.
Circulation research 2008;102(8):986-93.
2007: Jeremiah Stitham; Eric J Arehart; Scott R Gleim; N Li; Karen Douville; John Hwa
New insights into human prostacyclin receptor structure and function through natural and synthetic mutations of transmembrane charged residues.
British journal of pharmacology 2007;152(4):513-22.
2007: Jeremiah Stitham; Eric J Arehart; Scott R Gleim; Karen Douville; Todd Mackenzie; John Hwa
Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR).
Gene 2007;396(1):180-7.
2007: Jeremiah Stitham; Eric J Arehart; Scott R Gleim; Karen Douville; John Hwa
Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations.
Prostaglandins & other lipid mediators 2007;82(1-4):95-108.
2006: Jeremiah Stitham; Scott R Gleim; Karen Douville; Eric J Arehart; John Hwa
Versatility and differential roles of cysteine residues in human prostacyclin receptor structure and function.
The Journal of biological chemistry 2006;281(48):37227-36.
2003: Kristen A McEachern; William B Archey; Karen Douville; Bradley A Arrick
BRCA1 splice variants exhibit overlapping and distinct transcriptional transactivation activities.
Journal of cellular biochemistry 2003;89(1):120-32.
2002: Stephen W Tobin; Karen Douville; Ulrike Benbow; Constance E Brinckerhoff; Vincent A Memoli; Bradley A Arrick
Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Oncogene 2002;21(1):108-18.
2001: S W Tobin; Mary Kay Brown; Karen Douville; D C Payne; Alan Eastman; Bradley A Arrick
Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2001;12(2):109-17.